GLMD - Galmed Pharmaceuticals Ltd
IEX Last Trade
3.27
0.108 3.303%
Share volume: 410,587
Last Updated: Fri 30 Aug 2024 09:56:48 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.16
0.11
3.42%
Summary score
24%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
23%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.55%
Return on assets
-13.94%
Return on sales
0%
Return on invested capital
128.75%
Total debt ratio
15.51%
Debt ratio change over timeo
-0.87%
Current Ratio
16.02%
Quick Ratio
0%
Cash Position Ratio
4.27%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.97%
Return on assets
-8.77%
Return on sales
0%
Return on invested capital
142.99%
Total debt ratio
7.31%
Debt ratio change over timeo
-0.95%
Current Ratio
15.81%
Quick Ratio
0%
Cash Position Ratio
2.89%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.23%
Return on assets
-8.97%
Return on sales
0%
Return on invested capital
135.57%
Total debt ratio
7.66%
Debt ratio change over time
-0.94%
Current Ratio
13.62%
Quick Ratio
0%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-115.46%
Return on assets
-111.56%
Return on sales
0%
Return on invested capital
6.64%
Total debt ratio
-87.03%
Debt ratio change over time
-0.87%
Current Ratio
14.53%
Quick Ratio
0%
Cash Position Ratio
3.08%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GLMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.55% | -3.05% | 11.55% | 6.27% |
| Return on assets | -13.94% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 128.75% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 61% |
| Total debt ratio | 15.51% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.87% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 15.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.89% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 17% | 34% | 36% |
| Short-term ratios | GLMD | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.97% | -25.62% | 17.94% | 7.14% |
| Return on assets | -8.77% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 142.99% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 40% | 71% | 61% |
| Total debt ratio | 7.31% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.95% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 15.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.89% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 33% | 25% | 43% |